Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia

Molecular Diagnosis

Volumn 8, Issue 1, 2004, Pages 57-64

  Sathish, Narayanan ^a   Abraham, Priya ^a   Peedicayil, Abraham ^a   Sridharan, Gopalan ^a   John, Subhashini ^a   Chandy, George ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PROTEIN E6; PROTEIN E7; TUMOR SUPPRESSOR PROTEIN; VIRUS DNA;

ADULT; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; EPISOME; FEMALE; GENE EXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIRUS DETECTION; VIRUS DNA CELL DNA INTERACTION; VIRUS ONCOGENE; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; GENES, VIRAL; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, VIRAL; UTERINE CERVICAL NEOPLASMS;

EID: 3342941447     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.2165/00066982-200408010-00008     Document Type: Article

References (48)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer, J Clin Pathol 2002; 55: 244-65
2. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9
3. De Villiers EM. Heterogeneity of the human papillomavirus group. J Virol 1989; 63: 4898-903
4. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27
5. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 63-73
6. Woodworth CD, Doniger J, Dipaolo JA. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol 1989; 63: 159-64
7. Watanabe S, Kanda T, Yoshiike K. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol 1989; 63: 965-9
8. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-9
9. Dyson N, Howley PM, Munger K, et al. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-7
10. Smotkin D, Prokoph H, Wettstein FO. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol 1989; 63: 1441-7
11. Romanczuk H, Thierry F, Howley PM. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol 1990; 64: 2849-59
12. Yee C, Krishnan-Hewlett I, Baker CC, et al. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985; 119: 361-6
13. Schwarz E, Freese UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314: 111-4
14. Lazo PA. Papillomavirus integration: prognostic marker in cervical cancer? Am J Obstet Gynecol 1997; 176: 1121-2
15. Kozuka T, Aoki Y, Nakagawa K, et al. Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies. Jpn J Cancer Res 2000; 91: 271-9
16. Dong XP, Stubenrauch F, Beyer-Finkler E, et al. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 1994; 58: 803-8
17. Fujii T, Tsukazaki K, Kiguchi K, et al. The major E6/E7 transcript of HPV-16 in exfoliated cells from cervical neoplasia patients. Gynecol Oncol 1995; 58: 210-5
18. Sotlar K, Selinka HC, Menton M, et al. Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR. Gynecol Oncol 1998; 69: 114-21
19. McNicol P, Guijon F, Wayne S, et al. Expression of human papillomavirus type 16 E6-E7 open reading frame varies quantitatively in biopsy tissue from different grades of cervical intraepithelial neoplasia. J Clin Microbiol 1995; 33: 1169-73
20. Ting Y, Manos MM. Detection and typing of genital human papillomaviruses. In: Innis M, Gelfand D, Sninsky J, et al., editors. PCR protocols: a guide to methods and applications. San Diego (CA): Academic Press Inc, 1990: 356-67
21. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265: 472-7
22. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170: 1077-85
23. Seedorf K, Krammer G, Durst M, et al. Human papillomavirus type 16 DNA sequence. Virology 1985; 145: 181-5
24. Falcinelli C, Claas E, Kleter B, et al. Detection of human papillomavirus type 16 mRNA transcripts in cytological abnormal scrapings. J Med Virol 1992; 37: 93-8
25. Coombs NJ, Gough AC, Primrose JN. Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res 1999; 27: e12
26. Park JSP, Hwang ES, Park SN, et al. Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol 1997; 65: 121-9
27. Shirasawa H, Tomita Y, Kubota K, et al. Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J Virol 1988; 62: 1022-7
28. Falcinelli C, van Belkum A, Schrauwen L, et al. Absence of human papillomavirus type 16 E6 transcripts in HPV 16-infected, cytologically normal cervical scrapings. J Med Virol 1993; 40: 261-5
29. Nakagawa S, Yoshikawa H, Yasugi T, et al. Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type. J Med Virol 2000; 62: 251-6
30. Czegledy J, losif C, Hansson BG, et al. Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer? Int J Cancer 1995; 64: 211-5
31. Rose BR, Thompson CH, Tattersall MH, et al. Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/ polymerase chain reaction. Gynecol Oncol 1995; 56: 239-44
32. Smits HL, van Gemen B, Schukkink R, et al. Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts. J Virol Methods 1995; 54: 75-81
33. Cornelissen MT, Smits HL, Briet MA, et al. Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J Gen Virol 1990; 71: 1243-6
34. Shirasawa H, Tanzawa H, Matsunaga T, et al. Quantitative detection of spliced E6-E7 transcripts of human papillomavirus type 16 in cervical premalignant lesions. Virology 1991; 184: 795-8
35. Forslund O, Lindqvist P, Haadem K, et al. HPV 16 DNA and mRNA in cervical brush samples quantified by PCR and microwell hybridization. J Virol Methods 1997; 69: 209-22
36. Hsu EM, McNicol PJ, Guijon FB, et al. Quantification of HPV-16 E6-E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction. Int J Cancer 1993; 55: 397-401
37. Durst M, Kleinheinz A, Hotz M, et al. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 1985: 66 (Pt 7): 1515-22
38. Lehn H, Krieg P, Sauer G. Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity. Proc Natl Acad Sci U S A 1985; 82: 5540-4
39. Cullen AP, Reid R, Campion M, et al. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991; 65: 606-12
40. Das BC, Sharma JK, Gopalkrishna V, et al. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 1992; 36: 239-45
41. Daniel B, Rangarajan A, Mukherjee G, et al. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol 1997; 78 (Pt 5): 1095-101
42. Meanwell CA, Cox MF, Blackledge G, et al. HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia. Lancet 1987; 1: 703-7
43. Matsukura T, Koi S, Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 1989; 172: 63-72
44. Casas L, Galvan SC, Ordonez RM, et al. Asian-American variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int J Cancer 1999; 83: 449-55
45. Giannoudis A, Duin M, Snijders PJ, et al. Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer 2001; 84: 1058-63
46. Ham J, Steger G, Yaniv M. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. EMBO J 1994; 13: 147-57
47. Chan WK, Klock G, Bernard HU. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol 1989; 63: 3261-9
48. Chong T, Chan WK, Bernard HU. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res 1990; 18: 465-70